These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20700621)

  • 21. Greater aortic stiffness is associated with renal dysfunction in participants of the ELSA-Brasil cohort with and without hypertension and diabetes.
    Cândido JSA; Camelo LV; Mill JG; Lotufo PA; Ribeiro ALP; Duncan BB; Brant LCC; Barreto SM
    PLoS One; 2019; 14(2):e0210522. PubMed ID: 30716076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).
    Haynes R; Staplin N; Emberson J; Herrington WG; Tomson C; Agodoa L; Tesar V; Levin A; Lewis D; Reith C; Baigent C; Landray MJ;
    Am J Kidney Dis; 2014 Jul; 64(1):40-8. PubMed ID: 24613056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney Function After a Hypertensive Disorder of Pregnancy: A Longitudinal Study.
    Paauw ND; van der Graaf AM; Bozoglan R; van der Ham DP; Navis G; Gansevoort RT; Groen H; Lely AT
    Am J Kidney Dis; 2018 May; 71(5):619-626. PubMed ID: 29289477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.
    Kim ED; Tanaka H; Ballew SH; Sang Y; Heiss G; Coresh J; Matsushita K
    Am J Kidney Dis; 2018 Nov; 72(5):682-690. PubMed ID: 30007506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
    Iwase M; Ide H; Ohkuma T; Fujii H; Komorita Y; Yoshinari M; Oku Y; Higashi T; Nakamura U; Kitazono T
    Clin Exp Nephrol; 2022 Feb; 26(2):122-131. PubMed ID: 34581896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of chronic kidney disease in cardiovascular disease: are we different from others?
    Iseki K
    Clin Exp Nephrol; 2011 Aug; 15(4):450-5. PubMed ID: 21465119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline General Characteristics of the Korean Chronic Kidney Disease: Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
    Kang E; Han M; Kim H; Park SK; Lee J; Hyun YY; Kim YS; Chung W; Kim HJ; Oh YK; Ahn C; Oh KH
    J Korean Med Sci; 2017 Feb; 32(2):221-230. PubMed ID: 28049232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognosis of subjects showing a reduced estimated glomerular filtration rate without albuminuria in Japanese patients with type 2 diabetes: a cohort study for diabetic kidney disease.
    Ito H; Antoku S; Izutsu T; Kusano E; Matsumoto S; Yamasaki T; Mori T; Togane M
    Clin Exp Nephrol; 2020 Nov; 24(11):1033-1043. PubMed ID: 32734506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting.
    Völler H; Gitt A; Jannowitz C; Karoff M; Karmann B; Pittrow D; Reibis R; Hildemann S
    Eur J Prev Cardiol; 2014 Sep; 21(9):1125-33. PubMed ID: 23508927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between low blood pressure and renal/cardiovascular outcomes in Japanese patients with chronic kidney disease under nephrologist care: the Gonryo study.
    Yamamoto T; Nakayama M; Miyazaki M; Matsushima M; Sato T; Taguma Y; Sato H; Ito S
    Clin Exp Nephrol; 2015 Oct; 19(5):878-86. PubMed ID: 25648765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia.
    Tanaka K; Hara S; Kushiyama A; Ubara Y; Yoshida Y; Mizuiri S; Aikawa A; Kawatzu S
    Clin Exp Nephrol; 2011 Jun; 15(3):391-397. PubMed ID: 21331740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease: findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease study.
    Düzova A; Karabay Bayazit A; Canpolat N; Niemirska A; Kaplan Bulut I; Azukaitis K; Karagoz T; Oguz B; Erdem S; Anarat A; Ranchin B; Shroff R; Djukic M; Harambat J; Yilmaz A; Yildiz N; Ozcakar B; Büscher A; Lugani F; Wygoda S; Tschumi S; Zaloszyc A; Jankauskiene A; Laube G; Galiano M; Kirchner M; Querfeld U; Melk A; Schaefer F; Wühl E;
    J Hypertens; 2019 Nov; 37(11):2247-2255. PubMed ID: 31205198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
    Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods.
    Oh KH; Park SK; Park HC; Chin HJ; Chae DW; Choi KH; Han SH; Yoo TH; Lee K; Kim YS; Chung W; Hwang YH; Kim SW; Kim YH; Kang SW; Park BJ; Lee J; Ahn C;
    BMC Nephrol; 2014 May; 15():80. PubMed ID: 24884708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
    Wheeler DC; Stefansson BV; Batiushin M; Bilchenko O; Cherney DZI; Chertow GM; Douthat W; Dwyer JP; Escudero E; Pecoits-Filho R; Furuland H; Górriz JL; Greene T; Haller H; Hou FF; Kang SW; Isidto R; Khullar D; Mark PB; McMurray JJV; Kashihara N; Nowicki M; Persson F; Correa-Rotter R; Rossing P; Toto RD; Umanath K; Van Bui P; Wittmann I; Lindberg M; Sjöström CD; Langkilde AM; Heerspink HJL
    Nephrol Dial Transplant; 2020 Oct; 35(10):1700-1711. PubMed ID: 32862232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury.
    James MT; Grams ME; Woodward M; Elley CR; Green JA; Wheeler DC; de Jong P; Gansevoort RT; Levey AS; Warnock DG; Sarnak MJ;
    Am J Kidney Dis; 2015 Oct; 66(4):602-12. PubMed ID: 25975964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.